Chat with us, powered by LiveChat

Teva Venture to Boost P&G

Procter & Gamble and Teva unveiled details of a joint venture to develop branded generic medicines. P&G also boosted its full-year earnings guidance to include contributions from the venture, as well as a gain from the planned divestiture of Pringles. more